Style | Citing Format |
---|---|
MLA | Rezaeeniya F. "Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”." Clinical and Translational Oncology, vol. 22, no. 10, 2020, pp. 1907-. |
APA | Rezaeeniya F (2020). Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”. Clinical and Translational Oncology, 22(10), 1907-. |
Chicago | Rezaeeniya F. "Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”." Clinical and Translational Oncology 22, no. 10 (2020): 1907-. |
Harvard | Rezaeeniya F (2020) 'Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”', Clinical and Translational Oncology, 22(10), pp. 1907-. |
Vancouver | Rezaeeniya F. Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”. Clinical and Translational Oncology. 2020;22(10):1907-. |
BibTex | @article{ author = {Rezaeeniya F}, title = {Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis”}, journal = {Clinical and Translational Oncology}, volume = {22}, number = {10}, pages = {1907-}, year = {2020} } |
RIS | TY - JOUR AU - Rezaeeniya F TI - Letter to Editor Regarding “The Risk of Malignancies in Patients Receiving Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis” JO - Clinical and Translational Oncology VL - 22 IS - 10 SP - 1907 EP - PY - 2020 ER - |